Cargando…
Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis
Carvedilol is a widely used beta-adrenoreceptor antagonist for multiple cardiovascular indications; however, it may induce cholestasis in patients, but the mechanism for this effect is unclear. Carvedilol also prevents the development of various forms of experimental liver injury, but its effect on...
Autores principales: | Lastuvkova, Hana, Nova, Zuzana, Hroch, Milos, Alaei Faradonbeh, Fatemeh, Schreiberova, Jolana, Mokry, Jaroslav, Faistova, Hana, Stefela, Alzbeta, Dusek, Jan, Kucera, Otto, Hyspler, Radomír, Dohnalkova, Ester, Bayer, Rachel L, Hirsova, Petra, Pavek, Petr, Micuda, Stanislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682974/ https://www.ncbi.nlm.nih.gov/pubmed/37632784 http://dx.doi.org/10.1093/toxsci/kfad088 |
Ejemplares similares
-
Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis
por: Lastuvkova, Hana, et al.
Publicado: (2021) -
Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats
por: Alaei Faradonbeh, Fatemeh, et al.
Publicado: (2022) -
Iron overload reduces synthesis and elimination of bile acids in rat liver
por: Prasnicka, Alena, et al.
Publicado: (2019) -
Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis
por: Cristina Igreja Sá, Ivone, et al.
Publicado: (2023) -
Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver
por: Igreja Sá, Ivone Cristina, et al.
Publicado: (2020)